Bay Area
April 25, 2023- Addressing the Development & Manufacturing Challenges of Cell & Gene Therapies
September 8, 2022- Current & Future State of M&A
Darcy Mootz, Head, Amunix Pharmaceuticals
Jay Stamatis, VP & Head of BD & Acquisitions, AbbVie
Julianne Averill, CFO consultant, Danforth Advisors
Lori Hu, Managing Director, Vertex Ventures HC
Moderated by Samina Bari, Strategic Business Advisor, Cayuga Biotech
May 24, 2022- Status of the Industry
Anne Longmire, VP, JP Morgan
Brent Vaughan, CEO, Cognito Therapeutics
Mike Guerra, CEO, CA Life Sciences
Shelley Chu, Partner, Lightspeed Venture Partners
Moderated by Ben Conway, consultant, Danforth Advisors